- The first acceptance period for Takeda Pharmaceutical Company's (TKPYY) tender offer for all outstanding ordinary shares, warrants and ADSs of TiGenix NV that it does not already own will commence on April 30 and will expire on May 31 unless extended.
- Previously: Takeda to acquire TiGenix for €520M (Jan. 5)